Back to Directory
Last Updated: 08/06/2026
APIS Assay Technologies
Manchester
Founded 2018
Molecular diagnostic assay development for oncology biomarkers
APIS Assay Technologies is a molecular diagnostics company developing and commercialising genomic assays for oncology and personalised medicine.
The company combines an in-house biomarker research programme with contract assay development services, using PCR, digital PCR, and multi-omics platforms to translate biomarkers into clinical diagnostic products.
Its portfolio includes assays for breast cancer subtyping, ESR1 and PIK3CA mutation detection, and pharmacogenomic profiling.
APIS also offers bioinformatics services and proprietary aptamer technology for diagnostic and therapeutic applications.